Ashland Inc. has announced significant advancements in its global expansion strategy, focusing on enhancing profitability and operational consistency. The company is investing heavily in key international markets, including Ireland and the United States for its injectables business, Brazil for tablet coatings and microbial protection, China for biofunctionals actives, and both the United States and Europe for microbial protection. Additionally, Ashland is constructing a new tablet coating plant in India. These strategic investments align with the company's goal to optimize its manufacturing network, highlighted by a $60 million plan that includes the transfer of hydroxyethyl cellulose production from Parlin, New Jersey, to Hopewell, Virginia, and the consolidation of smaller plants into larger sites. Ashland's CEO, Guillermo Novo, emphasized that these moves are crucial for increasing market competitiveness and achieving cost savings, ultimately contributing to the company's growth and market share expansion.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。